Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy.
A Miquel Cases
,
L M G Steuten
,
V P Retèl
,
W H van Harten
More about this publication
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Volume
17
Issue nr.
7
Pages
A323
Publication date
01-11-2014
Full text links
Publisher website (DOI)
10.1016/j.jval.2014.08.567
Europe PubMed Central
27200529
Pubmed
27200529